BioCentury | Oct 17, 2020
Management Tracks

Merck KGaA’s Rossetti retires; plus moves at J&J, Innovent, eFFECTOR, Nautilus, Epirium and more

...million in its series C in 2017. Patel was CMO at Lyell Immunopharma Inc.Proteomic platform company Nautilus Biotechnology Inc....
...Ltd. hired Jian Kang as VP of IP. BC Staff Merck KGaA Johnson & Johnson Janssen Pharmaceuticals ​ Innovent Biologics Inc. Nautilus Biotechnology Inc. Medeor...
BioCentury | May 22, 2020
Finance

Nautilus raises $76M series B to deliver next-generation proteomics to the lab

...existing investors AME Cloud Ventures, Andreessen Horowitz, Bolt and Madrona Venture Group. The round brings Nautilus Biotechnology Inc.’s...
...performs proteomic analyses for partners. He declined to disclose specific partnerships. Elizabeth S. Eaton, Staff Writer Vulcan Capital Nautilus Biotechnology Inc. proteomics proteome...
Items per page:
1 - 2 of 2
BioCentury | Oct 17, 2020
Management Tracks

Merck KGaA’s Rossetti retires; plus moves at J&J, Innovent, eFFECTOR, Nautilus, Epirium and more

...million in its series C in 2017. Patel was CMO at Lyell Immunopharma Inc.Proteomic platform company Nautilus Biotechnology Inc....
...Ltd. hired Jian Kang as VP of IP. BC Staff Merck KGaA Johnson & Johnson Janssen Pharmaceuticals ​ Innovent Biologics Inc. Nautilus Biotechnology Inc. Medeor...
BioCentury | May 22, 2020
Finance

Nautilus raises $76M series B to deliver next-generation proteomics to the lab

...existing investors AME Cloud Ventures, Andreessen Horowitz, Bolt and Madrona Venture Group. The round brings Nautilus Biotechnology Inc.’s...
...performs proteomic analyses for partners. He declined to disclose specific partnerships. Elizabeth S. Eaton, Staff Writer Vulcan Capital Nautilus Biotechnology Inc. proteomics proteome...
Items per page:
1 - 2 of 2